Beauty-from-Within Supplements: Clinical Evidence That Improves Skin, Hair and Biological Aging

Table of Contents

1. Key Highlights:
2. Introduction
3. Resveratrol and Polyphenols: More Than Antioxidants
4. Olive Leaf Extract and Postmenopausal Skin: Preserving Elastin
5. Pycnogenol and Vascular-Lymphatic Support: Lipedema and Cellulite
6. Sirtuins: DNA Repair and the Anti-Aging Trinity for Skin
7. Botanical Blends and Dual-Route Strategies: Astragalus, Centella and Eternalyoung
8. Collagen Precursors and Peptides: From Amino Acid Ratios to Reduced Biological Age
9. Hyaluronic Acid, Curcumin and Keratin: Targeted Benefits for Hydration, Oxidation and Hair Anchoring
10. NMN and Hair Growth: NAD+ Pathways in Dermatology
11. Acne and Microbiome-Targeted Formulations: Nutrafol Skin and Beyond
12. Photoaging: Which Supplements Protect Against UV Damage?
13. Personalized Responses: The Microbiome, S-Equol and Why One Size Fails
14. Safety, Tolerability and Study Limitations
15. How to Choose a Beauty-from-Within Supplement: Evidence-Based Criteria
16. Integrating Supplements with Topical Care and Lifestyle
17. Market Trends and the Road Ahead
18. Practical Profiles: What the Evidence Supports Today
19. Research Gaps and Priority Questions
20. Conclusion (integrated guidance)
21. FAQ

Key Highlights:

• A growing body of randomized clinical trials links specific oral supplements—resveratrol, collagen precursors, botanical blends, polyphenols and targeted amino acids—to measurable improvements in wrinkles, skin elasticity, hair thickness and markers of biological aging.
• Effects depend on ingredient, formulation, dose and individual factors such as age, sex and microbiome status; combining topical and oral approaches and choosing microbiome-aware products often yields stronger outcomes.
• Most trials report good tolerability, but limitations—small sample sizes, short durations and inconsistent biomarker use—underline the need for larger, longer studies to confirm mechanisms and optimal regimens.

Introduction

Consumers have long pursued "beauty-from-within" remedies. Recent trials have moved those remedies out of anecdote and into controlled science. Over the past two years, peer-reviewed studies and industry-sponsored clinical trials have produced reproducible signals: certain botanical extracts, collagen precursors, polyphenols and amino-acid combinations deliver quantifiable improvements to skin architecture, hair growth and physiological markers associated with aging. These results span different populations—postmenopausal women, younger adults, men with thinning hair—and examine outcomes from wrinkle depth to biological age.

The emerging evidence does not present a single miracle pill. Instead it reveals a layered picture: ingredients act through antioxidant, anti-inflammatory, microcirculatory and metabolic pathways; the gut microbiome often mediates efficacy; and multi-modal strategies that pair oral supplements with topical agents or lifestyle measures tend to deliver the clearest benefits. The following analysis synthesizes the latest clinical reports, highlights mechanisms tied to real-world products, and identifies where the science is settled and where it still needs clarification.

Resveratrol and Polyphenols: More Than Antioxidants

Resveratrol, a polyphenol famously associated with red wine, has long been touted for antioxidant properties. New clinical data expand that story. A double-blind trial of Lallemand’s Veri-te resveratrol in women over 40 tested an oral-plus-topical regimen against placebo and found significant wrinkle reduction and increased sebum production in the treated group. The trial enrolled 132 participants and measured visible skin changes, supporting resveratrol’s role in dermal improvement when delivered in a bioavailable form and combined routes.

Mechanisms identified by investigators extend beyond free-radical scavenging. Resveratrol activates sirtuins and AMPK pathways, improves microvascular blood flow and interacts with gut microbial metabolism. Researchers now emphasize resveratrol metabolites—produced when gut bacteria break down polyphenols—as the likely active mediators in human physiology. Those metabolites may explain why some resveratrol formulations outperform others: bioavailability and the microbiome’s capacity to convert parent compounds into active forms determine clinical outcomes.

Real-world implication: choosing a resveratrol product matters. Formulations designed for enhanced bioavailability and those that consider the gut-skin axis will likely outperform plain resveratrol powders. Brands are responding by pairing oral formulations with topical applications and by investing in stabilized or microencapsulated forms to preserve activity.

Olive Leaf Extract and Postmenopausal Skin: Preserving Elastin

Solabia Nutrition’s Bonolive, a standardized olive leaf extract (40% oleuropein), produced signals of benefit for postmenopausal skin. In clinical testing, Bonolive intake correlated with preservation of elastin and reductions in pentosidine, a marker of glycation-related cellular aging. While broad systemic biomarkers did not shift dramatically, subgroup analyses showed improvements in dermal microstructure, suggesting the extract's effects are localized to skin extracellular matrix processes.

Oleuropein and related phenolics exert antioxidant and anti-inflammatory activity and inhibit glycation—key mechanisms in preserving the extracellular matrix. For postmenopausal women, when estrogen decline accelerates extracellular matrix breakdown, agents that protect elastin and collagen take on particular importance. The Bonolive data suggest that an olive leaf extract standardized for active phenolics can be a targeted option in formulations for this demographic.

Clinical nuance: results were stronger on tissue-level markers than on whole-body biomarkers, which makes mechanistic sense given topical-like, localized action patterns. This emphasizes the value of dermal imaging and biopsy endpoints in skin supplement trials, rather than reliance on plasma biomarkers alone.

Pycnogenol and Vascular-Lymphatic Support: Lipedema and Cellulite

Pycnogenol, an extract of French maritime pine bark (Pinus pinaster), has been the subject of multiple trials for vascular and skin outcomes. A 60-day study in 100 participants with lipedema reported a 29% symptom reduction in the treated group, including improvements in sensitivity, bruising and body composition without adverse effects. Another randomized, double-blind trial in 60 Han Chinese women found a 12–13% reduction in cellulite scores and decreases in thigh circumference and skin roughness after 2–3 months of supplementation.

Mechanistically, Pycnogenol’s polyphenolic profile strengthens capillary walls, improves microcirculation, attenuates inflammation and supports lymphatic flow. Those actions address core pathophysiology in lipedema—excessive fat accumulation, microvascular dysfunction and lymphatic impairment—and in cellulite—microcirculatory stasis and dermal structural changes.

Clinical applications: for patients with vascular fragility, bruising or early lipedema signs, Pycnogenol offers an evidence-backed oral option. Its tolerability profile is favorable, but practitioners should consider dose, duration and individual vascular risk factors when recommending it.

Sirtuins: DNA Repair and the Anti-Aging Trinity for Skin

Sirtuins—SIRT1, SIRT3 and SIRT6—emerged as central regulators of cellular longevity in recent conference presentations and publications. These NAD+-dependent deacetylases modulate genomic stability, mitochondrial function and metabolic homeostasis. Research presented by Estée Lauder Companies highlighted sirtuins as integral to transcriptional programs that preserve skin structure, maintain mitochondrial capacity and support DNA repair pathways.

SIRT2 also appears relevant to maintaining cytoskeleton integrity and cellular elasticity; studies note morphological differences between older, more rounded skin cells and younger, elongated, elastic cells, driven in part by sirtuin expression. Interventions that increase NAD+ availability—such as nicotinamide mononucleotide (NMN) supplementation—may therefore modulate sirtuin activity and downstream skin and hair phenotypes.

Translational insight: products aimed at supporting NAD+ metabolism (e.g., NMN) or directly activating sirtuins are becoming attractive targets for researchers and formulators. Clinical signals linking NMN to improvements in hair parameters offer an early human validation of the pathway, though long-term skin outcomes remain to be confirmed.

Botanical Blends and Dual-Route Strategies: Astragalus, Centella and Eternalyoung

A Taiwanese randomized, double-blind, placebo-controlled trial examined a dual-use approach: an Astragalus membranaceus and Centella asiatica saponin blend (ACS) used both topically and orally. In 150 adults, the combined regimen produced the largest gains in brightness, moisture, elasticity, collagen content and pigmentation improvements.

Parallel research on Monteloeder’s Eternalyoung—a botanical blend of pomegranate, sweet orange, desert ginseng and gotu kola—reported a 23% reduction in forehead wrinkles among 71 women over 12 weeks, alongside improved radiance and pigmentation markers. Over 80% of participants in the treatment group experienced visible improvements.

These studies underline a practical lesson: combining systemic and topical delivery often amplifies outcomes. Oral botanicals target deeper dermal matrix turnover, inflammatory signaling and systemic antioxidant capacity, while topical formulations address barrier function and surface hydration. The two routes overlap in mechanisms, producing both superficial and structural improvements.

Real-world strategy: brands and clinicians should consider synchronizing topical and oral regimens. For consumers, pairing an evidence-backed oral botanical with dermatologist-recommended topicals can accelerate visible improvements and sustain results.

Collagen Precursors and Peptides: From Amino Acid Ratios to Reduced Biological Age

Collagen-centered interventions produced some of the most striking data. Avea Life’s Collagen Activator—built around Colgevity, a patented vegan collagen precursor with glycine:proline:hydroxyproline in a 3:1:1 ratio—was tested for six months and associated with dermatological improvements and a 1.4-year reduction in calculated biological age. The trial incorporated cellular and preclinical evidence across species: effects observed in C. elegans, mice and human fibroblasts translated into visible human skin changes.

Separate trials of low-molecular-weight collagen peptides showed rapid effects: a South Korean study found that 1,650 mg daily of NS Collagen Peptide produced significant improvements in wrinkles, elasticity, hydration and pore size within eight weeks. A larger trial of fish collagen peptides combined with L-cystine in 198 Asian women reported benefits for hydration and dermal thickness in older women and improved texture and UV protection in younger women.

Mechanistic backing is robust. Collagen precursors supply glycine, proline and hydroxyproline—substrates for collagen synthesis—and peptide fragments may stimulate fibroblast activity and extracellular matrix remodeling. Alpha-ketoglutarate, astaxanthin and vitamin C (the latter stabilizing collagen formation) added to certain formulations further support collagen biosynthesis and antioxidant defense.

Clinical caution: not all collagen supplements are created equal. Molecular weight, peptide profile and concentration matter for absorption and bioactivity. Evidence supports both marine and vegan precursor strategies, but transparency on formulation and standardized dosing improves the ability to predict outcomes.

Hyaluronic Acid, Curcumin and Keratin: Targeted Benefits for Hydration, Oxidation and Hair Anchoring

Hyaluronic acid (HA) and wheat oil extract were combined in Ritual’s HyaCera supplement and tested in a 63-person trial. Across skin types and ages (26–64), the formulation improved hydration, elasticity and reduced wrinkle depth over the study period, reflecting HA’s capacity to influence deeper dermal hydration and wheat oil’s barrier-supporting profile.

Lubrizol’s microencapsulated curcumin (Curcushine) produced wrinkle-area reductions and decreased redness and brown spots after six weeks in 63 women. Microencapsulation addresses curcumin's classic bioavailability challenge, and the trial linked reduced reactive oxygen species and modulation of collagen synthesis as likely mechanisms.

For hair structure, oxidized keratin supplementation (KeraGEN-IV) delivered clinically meaningful results in women aged 45–60: a 43% reduction in hair loss with increased skin elasticity after 60 days. Keratin’s effects were attributed to enhanced keratinocyte migration and increased expression of collagen type IV, important for epidermal-dermal junction integrity and hair anchorage.

Practical takeaway: ingredients that directly target hydration, oxidative stress and structural proteins can produce rapid, noticeable outcomes. Formulation—such as microencapsulation or specific oxidation states of keratin—can be decisive for efficacy.

NMN and Hair Growth: NAD+ Pathways in Dermatology

A 12-week study of 500 mg daily nicotinamide mononucleotide (NMN) in 15 Japanese women aged 40–50 reported improved anagen hair elongation density and larger hair diameter, despite a small drop in total hair count likely due to seasonal shedding. Investigators attributed improvements to enhanced follicle maturation and improved nutrient supply to dermal papilla cells via increased NAD+ and sirtuin pathway activation.

This trial is among the first to connect NAD+-boosting supplementation directly to hair growth metrics. The mechanism—improving mitochondrial function and energy metabolism in hair follicles—aligns with sirtuin biology and broader longevity research.

Clinical perspective: NMN may be most effective for enhancing the quality of existing terminal hairs rather than increasing absolute hair count. Larger, placebo-controlled studies across seasons and ethnically diverse cohorts will be needed to confirm and generalize findings.

Acne and Microbiome-Targeted Formulations: Nutrafol Skin and Beyond

Nutrafol Skin, targeting mild-to-moderate adult female acne, combines botanicals, probiotics and postbiotics with ceramides and antioxidants. A 12-week randomized trial of 102 participants showed reduced breakouts, redness and improved texture and hydration. Ingredients such as holy basil, maca, berberine, curcumin and Lactobacillus plantarum postbiotic target acne’s multifactorial drivers: stress, hormonal imbalance and microbiome dysbiosis.

The trial demonstrates the value of holistic, root-cause-targeting formulations for adult acne. Rather than focusing solely on sebum reduction or topical bactericidal approaches, oral supplements that modulate inflammation, hormonal signaling and the gut-skin axis can provide adjunctive benefits.

Usage note: combining oral microbiome-aware supplements with established topical or systemic acne therapies requires professional oversight to avoid interactions and to set realistic expectations about time to improvement.

Photoaging: Which Supplements Protect Against UV Damage?

A systematic review in Frontiers in Medicine evaluated dietary supplements for protection against UV-induced photoaging. The strongest evidence exists for collagen supplements and flavanols, which improved dermal parameters and, in the case of flavanols, minimal erythema dose (MED)—a metric of UV sensitivity. Polyphenols showed mixed results; carotenoids, lycopene and astaxanthin require more rigorous trials to substantiate consistent photoprotective effects.

All supplements in the review were safe over study durations (typically up to 24 weeks). Key mechanistic targets include reduction of UV-induced oxidative stress, attenuation of inflammation and preservation of collagen integrity. Supplements should be viewed as adjuncts to, not replacements for, sunscreen and behavioral UV avoidance. For consumers seeking photoprotection, combining evidence-backed oral options (collagen, flavanols) with topical sunscreen and antioxidants offers layered defense.

Personalized Responses: The Microbiome, S-Equol and Why One Size Fails

Several trials underscore variability in individual response. ADM’s study of Novasoy soy isoflavones found greater skin improvements among participants who were S-equol producers—an intestinal bacterial metabolite with estrogen-like activity. The implication is straightforward: microbiome composition modulates conversion of dietary isoflavones into bioactive compounds that then affect skin physiology.

Resveratrol studies show similar patterns: gut microbial metabolites are likely critical for translating resveratrol intake into skin benefits. These findings argue for personalized, microbiome-aware product development. Clinically, identifying who is likely to benefit from a given supplement may require simple metabolic assays or at least an appreciation of how diet, antibiotics and gut health shape response.

Practical implication: clinicians and formulators should incorporate microbiome considerations into clinical study designs and, when feasible, into consumer guidance—either by recommending prebiotics/probiotics alongside certain supplements or by tailoring product selection to likely metabolizer phenotypes.

Safety, Tolerability and Study Limitations

Across the trials summarized, safety profiles were generally favorable. Adverse events were rare and mild. Nevertheless, there are consistent methodological limitations:

• Small sample sizes: many studies enrolled fewer than 200 participants, limiting power to detect smaller effects or subgroup interactions.
• Short durations: several trials lasted 6–12 weeks; longer-term effects and safety over years remain less clear.
• Variable endpoints: some studies prioritized imaging and clinical grading, while others relied on participant-reported outcomes, complicating cross-trial comparisons.
• Heterogeneous formulations: dose, purity and co-ingredients vary widely, making ingredient-level generalization risky.
• Lack of standardized biomarkers: few trials pair clinical outcomes with validated molecular markers to clarify mechanism.

Regulatory and marketing pressures encourage rapid product launches, but robust, adequately powered, placebo-controlled and ideally multi-center trials remain essential to move the field from promising signals to definitive guidance.

How to Choose a Beauty-from-Within Supplement: Evidence-Based Criteria

Selecting an oral beauty product should follow practical, evidence-based steps.

1. Ingredient-Level Evidence: Prefer ingredients supported by randomized, placebo-controlled trials with clear endpoints—wrinkle depth, elasticity, hair diameter—rather than only in vitro data.
2. Formulation and Bioavailability: Look for delivery systems proven to enhance absorption—microencapsulation for curcumin, low-molecular-weight peptides for collagen, stabilized forms of resveratrol.
3. Dose Transparency: Effective clinical doses should be disclosed. A product listing a proprietary blend without doses limits interpretability.
4. Trial Population Match: Choose products tested in demographics that match your own (age range, sex, ethnicity) for greater likelihood of similar results.
5. Combined Strategies: Consider pairing oral supplements with topical regimens, as several studies show additive benefit.
6. Microbiome Considerations: If an ingredient requires metabolic activation (e.g., soy isoflavones producing S-equol), ask whether the product provides guidance on microbiome optimization or testing.
7. Safety and Interactions: Check for contraindications—particularly if taking prescription medications—or sensitivities to botanical ingredients. Consult a clinician before combining multiple active supplements.

Real-world example: a peri- or postmenopausal woman concerned about elastin loss and pigmentation could consider a product proven in that demographic (olive leaf extract standardized for oleuropein, plus a collagen precursor and topical retinoid), ensuring dosing matches clinical trials and seeking professional oversight.

Integrating Supplements with Topical Care and Lifestyle

Supplements are most effective when integrated with established dermatologic practice. Topical retinoids, vitamin C serums, sunscreen and procedures like chemical peels or lasers address immediate cellular turnover and pigmentation. Oral supplements address systemic drivers: collagen matrix support, antioxidant capacity, microcirculation and hormonal modulation.

Lifestyle remains foundational: adequate protein and vitamin C intake, sleep, stress management and UV avoidance amplify supplement effects. Exercise supports microcirculation and lymphatic flow, important in cellulite and lipedema contexts where Pycnogenol showed benefit. Smoking cessation and glycemic control reduce glycation and oxidative stress, increasing the odds that supplements will translate into visible improvements.

Case vignette: a 52-year-old woman with thinning skin, perimenopausal symptoms and mild cellulite could adopt a combined plan—Bonolive to preserve elastin, a collagen precursor to support matrix turnover, Pycnogenol for microcirculation, and a topical regimen for pigmentation. This multi-pronged approach matches mechanisms to phenotypes and echoes the combined strategies validated in trials.

Market Trends and the Road Ahead

The global market for beauty supplements will expand as evidence accumulates and consumers seek alternatives or complements to topical and procedural approaches. Promising directions include:

• Microbiome-guided personalization: diagnostic tests to identify S-equol producers or other metabolizer phenotypes will support targeted supplementation.
• Multi-target formulations: blends that couple amino acids, antioxidants and NAD+-supporting compounds aim to address both appearance and biological aging.
• Drug–nutraceutical hybrids: combinations of well-characterized actives and high-quality excipients, studied in rigorous trials, will raise the evidence bar.
• Longer-duration outcome studies: trials extending beyond six months, incorporating biopsies, transcriptomic and metabolomic endpoints, will clarify mechanisms and long-term safety.

Regulatory frameworks will increasingly demand substantiation for claims, pushing brands toward higher-quality clinical programs. Clinicians and consumers will benefit when marketed benefits align with published data.

Practical Profiles: What the Evidence Supports Today

• Resveratrol (oral + topical): Evidence of wrinkle reduction in women over 40 when bioavailable forms and combined routes are used. Gut microbial metabolites likely crucial.
• Olive leaf extract (Bonolive): Preserves elastin and reduces pentosidine in postmenopausal women—useful for estrogen-deficiency–driven ECM decline.
• Pycnogenol: Improves symptoms of lipedema and reduces cellulite severity by improving microcirculation and supporting lymphatic function.
• Collagen precursors and peptides (Colgevity, low-MW peptides, fish collagen): Rapid improvements in hydration, elasticity and wrinkles; some evidence for reduced biological age with multicomponent formulations.
• Botanical blends (Astragalus + Centella, Eternalyoung): Dual topical and oral use demonstrates amplified benefits for brightness, moisture and structural markers.
• NMN: Early evidence for enhancing hair diameter and anagen hair metrics via NAD+/sirtuin pathways.
• Hyaluronic acid formulations: Improve dermal hydration and elasticity when delivered orally in bioavailable forms.
• Curcumin (microencapsulated): Reduces wrinkle area and oxidative markers; bioavailability strategies are essential.
• Keratin: Reduces hair loss and improves skin elasticity in middle-aged women, likely through junctional protein support and keratinocyte migration stimulation.
• Isoflavones (Novasoy): Benefits concentrated among S-equol producers—personalized microbiome-aware use recommended.
• Acne-targeted supplements (Nutrafol Skin): Botanicals plus probiotics/postbiotics can reduce breakouts and improve texture in adult women.

Research Gaps and Priority Questions

• Which biomarkers reliably predict clinical response across ingredients?
• How do long-term safety and efficacy profiles evolve beyond six months or a year?
• What are the optimal combinations, doses and timing for synergistic effects across topicals and orals?
• Can standardized microbiome assays meaningfully guide product selection and improve response rates?
• How do ethnicity, baseline nutritional status and concurrent medications alter efficacy?

Addressing these questions will require coordinated multi-center trials, standardized endpoints and mechanistic sub-studies that pair clinical outcomes with tissue- and system-level biomarkers.

Conclusion (integrated guidance)

Clinical evidence for beauty-from-within supplements has matured beyond isolated preclinical reports. Randomized trials now demonstrate measurable improvements in skin and hair across diverse ingredient classes. The most persuasive findings come from formulations that combine mechanistically complementary actives, adopt delivery technologies that overcome bioavailability limits, and consider the microbiome’s role in metabolite generation.

Consumers and clinicians should prioritize products with transparent formulations, clinical backing that matches target demographics, and a plan that integrates oral supplementation with topical care and lifestyle interventions. Caution remains prudent: small study sizes and short durations limit certainty for some ingredients. Still, as larger, longer trials are completed and precision approaches develop, supplements will increasingly join dermatologic toolkits as evidence-based options for appearance and tissue health.

FAQ

Q: Are beauty-from-within supplements proven to work? A: Certain supplements have high-quality randomized trial support for specific outcomes—resveratrol combinations for wrinkle reduction, collagen peptides for hydration and elasticity, Pycnogenol for microcirculation-related conditions. Efficacy depends on ingredient, formulation, dose and the individual’s biology. Evidence is strongest when trials are placebo-controlled, use objective imaging or histological endpoints, and match the product use to the population studied.

Q: How long until I see results? A: Timelines vary by ingredient. Collagen peptides and low-molecular-weight formulations can show improvements in eight to twelve weeks. Botanical blends and polyphenols may require 8–12 weeks as well, with some trials running to six months for more pronounced effects. Hair-related endpoints (e.g., increased diameter, anagen density) were observed after 12 weeks in NMN studies. Individual response and baseline condition severity also influence timing.

Q: Can supplements replace topical skincare and sunscreen? A: Supplements complement topical care but do not replace sunscreen or active topical therapies like retinoids for many concerns. Oral agents address systemic drivers and can improve deeper dermal structures; topical agents remain essential for barrier repair, pigmentation control and immediate cellular turnover. For photoprotection, oral flavanols and collagen may provide adjunctive benefit but not sufficient protection on their own.

Q: Are these supplements safe? A: Trials generally report favorable safety and tolerability over study durations. However, long-term safety data are limited for some ingredients. Interactions with prescription medications—particularly hormonal agents, antiplatelet drugs, or immunosuppressants—require professional evaluation. Pregnancy and breastfeeding are contexts where caution and medical guidance are mandatory.

Q: What role does the gut microbiome play? A: The microbiome often converts parent compounds into active metabolites (e.g., S-equol from soy isoflavones; resveratrol metabolites). Those metabolites can determine clinical responsiveness. Microbiome composition, recent antibiotic use and diet can all influence outcomes. Personalized or microbiome-aware approaches may improve success rates for specific supplements.

Q: How should I choose a product? A: Look for randomized clinical evidence that matches your goal and demographic. Verify ingredient transparency, dosing, and bioavailability strategies. Prefer products with peer-reviewed trials and independent verification. Consider combination strategies—oral plus topical—when supported by trials.

Q: Can men benefit from these supplements? A: Yes. Trials include men—Nutrafol Men’s capsules demonstrated thicker, fuller hair in a six-month study of men aged 21–61. Many collagen and polyphenol studies included mixed-sex cohorts or men-specific arms. Matching the product to the condition and reviewing study populations improves predictability.

Q: Will taking multiple supplements provide faster results? A: Combining complementary supplements can be effective but increases complexity. Look for evidence supporting specific combinations rather than stacking many products haphazardly. Professional guidance helps avoid redundancy, potential interactions and excessive dosing of nutrients.

Q: What future developments should consumers watch for? A: Expect more microbiome-guided products, longer-duration trials that include molecular biomarkers and personalized formulations targeting NAD+ metabolism, sirtuin activation, and extracellular matrix preservation. Regulatory scrutiny and demand for clinical substantiation will raise standards across the category.

Q: Where can I find clinically validated products? A: Seek brands and products cited in peer-reviewed publications or registered clinical trials. Examples from recent research include Veri-te resveratrol formulations, Bonolive olive leaf extract, Pycnogenol, Colgevity-based collagen precursors, low-MW collagen peptides, Eternalyoung and ACS botanical combinations, Nutrafol formulations, Ritual’s HyaCera, Curcushine microencapsulated curcumin and KeraGEN keratin supplements. Always cross-check the peer-reviewed study for dosing and population details before purchasing.

If you plan to begin a new regimen, consult a qualified clinician—especially if you take prescription medications or have underlying health conditions—and consider tracking progress with photographs and, where available, objective skin imaging to measure outcomes against the clinical evidence.